Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sehested

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in miceS W Langer, M Sehested, P B Jensen
European Journal of Cancer & Clinical Oncology|October 1, 1981
Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lungM Sehested, F R Hirsch, K Hou-Jensen
Journal of Oral Pathology|July 1, 1985
Immunohistochemical investigation of lysozyme, lactoferrin, alpha 1-antitrypsin, alpha 1-antichymotrypsin and ferritin in parotid gland tumorsM Sehested, C Barfoed, A Krogdahl, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cellsM Sehested, D Simpson, T Skovsgaard, et al.
The British Journal of Radiology|April 1, 1987
Electron microscopy of ultrasound-guided fine-needle biopsy specimensM Sehested, N Juul, B Hainau, et al.
British Journal of Urology|February 1, 1985
Prostatic biopsy with the 21 gauge Surecut needle. A preliminary report of a new techniqueS Torp-Pedersen, N Juul, F Rasmussen, et al.
British Journal of Cancer|December 1, 1987
Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamilM Sehested, T Skovsgaard, B van Deurs, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicinB Holm, P B Jensen, M Sehested, et al.
Journal of the National Cancer Institute|January 1, 1987
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell linesM Sehested, T Skovsgaard, B van Deurs, et al.
Cancer Research|May 15, 1992
Relationship of VP-16 to the classical multidrug resistance phenotypeM Sehested, E Friche, P B Jensen, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in miceS W Langer, M Sehested, P B Jensen
European Journal of Cancer & Clinical Oncology|October 1, 1981
Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lungM Sehested, F R Hirsch, K Hou-Jensen
Journal of Oral Pathology|July 1, 1985
Immunohistochemical investigation of lysozyme, lactoferrin, alpha 1-antitrypsin, alpha 1-antichymotrypsin and ferritin in parotid gland tumorsM Sehested, C Barfoed, A Krogdahl, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cellsM Sehested, D Simpson, T Skovsgaard, et al.
The British Journal of Radiology|April 1, 1987
Electron microscopy of ultrasound-guided fine-needle biopsy specimensM Sehested, N Juul, B Hainau, et al.
British Journal of Urology|February 1, 1985
Prostatic biopsy with the 21 gauge Surecut needle. A preliminary report of a new techniqueS Torp-Pedersen, N Juul, F Rasmussen, et al.
British Journal of Cancer|December 1, 1987
Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamilM Sehested, T Skovsgaard, B van Deurs, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicinB Holm, P B Jensen, M Sehested, et al.
Journal of the National Cancer Institute|January 1, 1987
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell linesM Sehested, T Skovsgaard, B van Deurs, et al.
Cancer Research|May 15, 1992
Relationship of VP-16 to the classical multidrug resistance phenotypeM Sehested, E Friche, P B Jensen, et al.
Pageof 10